Search results

What is the IMF doing in practice to tackle inequality? Its main initiative has been a series of pilots that integrate inequality analysis into its economic surveillance of countries. This paper outlines Oxfam’s evaluation of these pilots and finds that they are not promoting policies that reduce inequality.

A year after WHO declared COVID-19 a global pandemic, the virus has laid bare the stark gender inequality that continues to shape our world. Despite being at the forefront of the response, women have borne the brunt of this crisis. On International Women's Day, we must reflect on why this happened and why it is absolutely critical for women and girls to have an equal voice and co-lead in rebuilding after COVID-19.

Following Oxfam’s January report revealing that just 85 people owned the same wealth as the bottom half the world’s population, Forbes has updated its “billionaires' list”, showing that extreme inequality has worsened– just 67 people at the top now own half the wealth.

New Oxfam analysis reveals huge carbon inequality in Europe. To achieve the deeper emissions cuts needed by 2030, European leaders must put fairness and a just transition at the heart of the Green Deal that tackles both inequality and emissions and can help build fairer, healthier and more resilient societies in the wake of the COVID-19 crisis.

The coronavirus pandemic has swept across a world unprepared to fight it. Only one in six countries assessed for the CRI Index 2020 were spending enough on health, and in more than 100 countries at least one in three workers had no labour protection such as sick pay.

In response to calls for a waiver of Trade and Intellectual Property Rules (TRIPS) for COVID-19 vaccines, which is backed by more than 100 mostly developing countries, being blocked again at World Trade Organisation talks by rich countries, Oxfam’s Health Policy Manager, Anna Marriott, said:“This is a massive missed opportunity to speed up and scale up the production of lifesaving vaccines worldwide by waiving the intellectual property barriers that prevent more qualified manufacturers joining the effort.

As the UN General Assembly kicks off again this year, Oxfam’s experts and partners are available to speak to their work focused on the People’s Vaccine for COVID-19, the climate crisis - including climate finance, and a number of pressing humanitarian crises. 

This week, world leaders came together on the sidelines of the 2023 Sustainable Development Goals (SDGs) Summit to urge for more global attention to addressing inequality. In a joint statement, they highlighted the urgency to save the inequality global goal (SDG10) and dramatically accelerate efforts to reduce inequality by adopting bolder targets and having more accurate tracking mechanisms.

New Oxfam research shows that four pharmaceutical corporations – Abbott, Johnson & Johnson, Merck & Co (MSD), and Pfizer – systematically hide their profits in overseas tax havens. This activity could deprive developing countries of more than $100 million every year – money that is urgently needed to meet the health needs of people in these countries.

In this report, Oxfam identifies three key issues that need to be tackled for Unilever to move to the next level of social impact and responsible sourcing and for the good intentions of their policies to translate into real impact for the lives of workers.